Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Respir Med ; 105(3): 371-6, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21093241

RESUMO

PURPOSE: Sputum analysis is important in COPD exacerbation management. We determined whether application of stringent quality control criteria for sputum samples had an impact on culture results. METHODS: We analyzed sputum samples of 108 patients during stable COPD and during exacerbations. To all samples quality control standards and culture interpretation rules according to the American Society of Microbiologists (ASM) were applied. RESULTS: In sputum exacerbation samples considered appropriate according to ASM quality standards, criteria for infection (40%) were met more often compared to inappropriate samples (13%) (p < 0.001). The same pattern was observed when applying these rules to sputum samples obtained during stable disease, (50% vs. 18%, p < 0.001). There was no difference in the percentage of infectious cultures obtained during the stable state and exacerbations. CONCLUSIONS: Applying stringent quality control criteria to sputum samples can have a profound effect on the labeling of sputum samples as infectious, and therefore on clinical decision making.


Assuntos
Tomada de Decisões , Testes de Sensibilidade Microbiana/normas , Doença Pulmonar Obstrutiva Crônica/microbiologia , Manejo de Espécimes/normas , Escarro/microbiologia , Adulto , Idoso , Técnicas de Laboratório Clínico , Feminino , Humanos , Masculino , Testes de Sensibilidade Microbiana/métodos , Pessoa de Meia-Idade , Controle de Qualidade
2.
Respir Med ; 103(4): 601-6, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19027281

RESUMO

BACKGROUND: When COPD patients present with an exacerbation, one cannot verify a bacterial cause of an exacerbation without time-consuming laboratory analyses. This makes it difficult to decide up front if antibiotic treatment is needed. Therefore, in clinical practice sputum colour and purulence are often used. OBJECTIVE: To determine whether sputum colour and purulence, assessed by the Stockley colour chart, correlated with overall bacterial load in COPD patients admitted for an exacerbation. To check the robustness of the colour and purulence assessment, we correlated the changes in these parameters and the corresponding change in bacterial load in sputum over the first seven days of hospitalisation. METHODS: Twenty-two COPD patients admitted to the hospital for an exacerbation were included. During the first seven days daily sputum samples were collected. RESULTS: A very weak association between bacterial load and sputum colour was found. There was no difference in bacterial load between patients with purulent sputum or not. Also, no consistent relationship between change in sputum colour and change in bacterial load during admission was found. CONCLUSIONS: The very weak association between bacterial load and sputum colour confirms concerns over the usefulness of the colour chart. The distinction between purulent and mucoid sputum at exacerbation is insufficient for distinction between patients who are likely to benefit from antibiotic therapy and those who are not. Complementary studies are needed to determine which other, easily measurable factors can be used as predictors for an indication for use of antibiotics; sputum colour is not the one.


Assuntos
Proteína C-Reativa/metabolismo , Interleucinas/metabolismo , Pigmentação , Doença Pulmonar Obstrutiva Crônica/microbiologia , Escarro/microbiologia , Doença Aguda , Idoso , Antibacterianos/uso terapêutico , Técnicas Bacteriológicas , Feminino , Hospitalização , Humanos , Interleucinas/sangue , Masculino , Pessoa de Meia-Idade , Países Baixos , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Supuração/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA